Dr Maria Carrieri and colleagues documented the relationship between anger dimensions, and quality of life in patients co-infected with HIV and hepatitis C virus (HCV).
The researchers performed a cross-sectional study nested in the ANRS CO13-HEPAVIH French national cohort.
Anger and quality of life were assessed using self-administered questionnaires in 536 HIV–HCV-co-infected patients.
Correlations between anger scores, and quality of life scores were assessed using Spearman’s coefficients.
Multiple linear regression models were then used to test the relationship between the different dimensions of anger and quality of life after adjustment for statistically significant psychosocial, sociobehavioral, and clinical characteristics.
The team found that patients with excessive alcohol use or history of injecting drug use had higher levels of anger.
The researchers noted that all dimensions of anger were significantly correlated with impaired quality of life for all 6 dimensions of the quality of life-HIV BREF scale.
Greater internal experience of anger and impaired anger control were confirmed as independent correlates of impaired quality of life related to psychological health, social relationships, and patients’ beliefs after adjustment for depressive symptoms, functional impact of fatigue, socioeconomic status, and HIV-related characteristics.
Dr Carrieri's team concluded, "Anger issues need close monitoring in HIV–HCV-co-infected patients, especially in patients with addictive behaviors."
"Screening for problems in anger management and implementing individualized psychotherapeutic strategies may help improve quality of life in this population."